Skip to content
Back to search

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Adalimumab, ATC L04AB04

AOK Rheinland-Pfalz/Saarland - Die GesundheitskasseGermanyPublished on Apr 09, 2026
576 days left

Description

Conclusion of non-exclusive rebate agreements pursuant to §§ 130a para. 8/130c para. 1 SGB V for medicinal products with the aforementioned active substance within the period from 01.06.2026 to 31.05.2028 with the possibility of concluding the contract at any time (open-house model). Medicinal products corresponding to the BfArM list according to § 35 para. 5a SGB V (paediatric medicinal products) are excluded from the open house procedure.

CPV codes

Pharmaceutical products

Documents & submission

AI summary
Sign in for an AI summary

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Related tenders